MindWalk Holdings HYFT
NASDAQ HYFT
$1.29 -0.06 (-4.44%)
At close: Sep 9, 2026 · 4:00 PM EDT

MindWalk Holdings (HYFT) Current Deferred Revenue (2020 - 2026)

MindWalk Holdings' (HYFT) quarterly Current Deferred Revenue came in at $782760.0 in Q2 2026, up 2.19% year-over-year from $765974.3 in Q2 2025, and up 15.44% quarter-over-quarter from $678056.1 in Q1 2026.

Analysis

MindWalk Holdings (HYFT) Current Deferred Revenue (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Current Deferred Revenue for 7 consecutive years, with $782760.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Deferred Revenue rose 2.19% year-over-year to $782760.0 in Q2 2026; TTM through Apr 2026 was $782760.0, a 2.19% increase from a year earlier, with the FY2026 full-year figure at $777614.3, down 0.62% from the prior year.
  • Current Deferred Revenue was $782760.0 for Q2 2026 at MindWalk Holdings, up from $678056.1 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $1.7 million in Q1 2025 and troughed at $565489.2 in Q3 2025.
  • A 5-year average of $929064.6 and a median of $830376.3 in 2022 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue soared 148.27% in 2024 and slumped 59.09% in 2026, its largest moves.
  • Over 5 years, Current Deferred Revenue stood at $885405.0 in 2022, then soared by 34.19% to $1.2 million in 2023, then grew by 5.83% to $1.3 million in 2024, then sank by 47.65% to $658162.5 in 2025, then increased by 18.93% to $782760.0 in 2026.
  • The last three Current Deferred Revenue figures came in at $782760.0 (Q2 2026), $678056.1 (Q1 2026), and $658162.5 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn
6 Evotec SE 661.34 Mn 235.46 Mn -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 782,759.96
Jan 31, 2026 678,056.09
Oct 31, 2025 658,162.53
Jul 31, 2025 565,489.20
Apr 30, 2025 765,974.27
Jan 31, 2025 1.66 Mn
Oct 31, 2024 1.26 Mn
Jul 31, 2024 950,135.88
Apr 30, 2024 997,127.42
Jan 31, 2024 1.50 Mn
Oct 31, 2023 1.19 Mn
Jul 31, 2023 844,352.69
Apr 30, 2023 722,051.05
Jan 31, 2023 602,753.66
Oct 31, 2022 885,405.02
Jul 31, 2022 1.08 Mn
Apr 30, 2022 816,400.01
Jan 31, 2022 776,650.25
Oct 31, 2021 1.03 Mn
Jul 31, 2021 1.02 Mn